1ABBV:BIT
AbbVie Common Stock
€230.10
arrow_downward
-0.60%(-1.40) 1D
Oct 2, 5:26:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 1ABBV...
Open
€232.20
High
€232.20
Low
€230.10
Mkt. cap
495.02B
Avg. vol.
38.00
Volume
26.00
52-wk high
€234.90
52-wk low
€168.00
No. of employees
57K
Open
€232.20
High
€232.20
Low
€230.10
Mkt. cap
495.02B
Avg. vol.
38.00
Volume
26.00
52-wk high
€234.90
52-wk low
€168.00
No. of employees
57K
News stories
From web sources and news partners
The Globe and Mail
·
26 minutes ago
Will Skyrizi & Rinvoq Drive AbbVie's Top-Line Growth in Q3?
ad-hoc-news.de
·
2 hours ago
AbbVie stock trades at EUR 249.65, P/ E 78.22
ad-hoc-news.de
·
6 hours ago
AbbVie presents 22 IBD abstracts and AbbVie stock costs EUR 247.55
ad-hoc-news.de
·
10 hours ago
AbbVie presents 22 IBD abstracts; stock pre-market at EUR 247.15, plus 0.59 percent
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com